MX21202A - Proceso para la preparacion de nuevos estereoisomeros y producto obtenido. - Google Patents

Proceso para la preparacion de nuevos estereoisomeros y producto obtenido.

Info

Publication number
MX21202A
MX21202A MX2120290A MX2120290A MX21202A MX 21202 A MX21202 A MX 21202A MX 2120290 A MX2120290 A MX 2120290A MX 2120290 A MX2120290 A MX 2120290A MX 21202 A MX21202 A MX 21202A
Authority
MX
Mexico
Prior art keywords
preparation
propylsulfinyl
hydroxypropoxy
propyl
ethyl
Prior art date
Application number
MX2120290A
Other languages
English (en)
Other versions
MX174254B (es
Inventor
Knut Olle Seved Almgren
Original Assignee
Haessle Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haessle Ab filed Critical Haessle Ab
Publication of MX21202A publication Critical patent/MX21202A/es
Publication of MX174254B publication Critical patent/MX174254B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C317/28—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to acyclic carbon atoms of the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fats And Perfumes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Separation By Low-Temperature Treatments (AREA)
  • Steroid Compounds (AREA)
  • Laminated Bodies (AREA)
  • Stereo-Broadcasting Methods (AREA)
MX021202A 1989-06-20 1990-06-18 Proceso para la preparacion de nuevos estereoisomeros y producto obtenido MX174254B (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8902237A SE8902237D0 (sv) 1989-06-20 1989-06-20 Novel stereoisomers

Publications (2)

Publication Number Publication Date
MX21202A true MX21202A (es) 1993-09-01
MX174254B MX174254B (es) 1994-05-02

Family

ID=20376342

Family Applications (1)

Application Number Title Priority Date Filing Date
MX021202A MX174254B (es) 1989-06-20 1990-06-18 Proceso para la preparacion de nuevos estereoisomeros y producto obtenido

Country Status (31)

Country Link
US (1) US5055490A (es)
EP (1) EP0404748B1 (es)
JP (1) JPH04506076A (es)
KR (1) KR920702676A (es)
CN (1) CN1048213A (es)
AT (1) ATE88698T1 (es)
AU (1) AU641665B2 (es)
BG (1) BG60164B2 (es)
CA (1) CA2058941A1 (es)
CZ (1) CZ278988B6 (es)
DE (1) DE69001461T2 (es)
DK (1) DK0404748T3 (es)
ES (1) ES2054325T3 (es)
FI (1) FI915937A0 (es)
HR (1) HRP920625A2 (es)
HU (1) HU211024B (es)
IE (1) IE902161A1 (es)
IL (1) IL94677A0 (es)
LT (1) LTIP1727A (es)
LV (1) LV10248A (es)
MX (1) MX174254B (es)
NO (1) NO914929L (es)
NZ (1) NZ234023A (es)
PH (1) PH27009A (es)
PL (1) PL163988B1 (es)
PT (1) PT94417A (es)
RU (1) RU2032663C1 (es)
SE (1) SE8902237D0 (es)
WO (1) WO1990015794A1 (es)
YU (1) YU120690A (es)
ZA (1) ZA904411B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8705150D0 (sv) * 1987-12-23 1987-12-23 Haessle Ab Novel antiarrhythmic agents
SE8902236D0 (sv) * 1989-06-20 1989-06-20 Haessle Ab Novel polystyrenesulfonate
SE8902235D0 (sv) * 1989-06-20 1989-06-20 Haessle Ab Novel cyclodextrin inclusion complexes
DE19546159A1 (de) 1995-12-11 1997-06-12 Liedtke Pharmed Gmbh Methode und Zusammensetzung einer topisch wirksamen Therapie postoperativer und posttraumatischer Wundschmerzen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1457876A (en) * 1972-12-15 1976-12-08 Ici Ltd Alkanolamine derivatives device for use in
GB1433920A (en) * 1973-10-01 1976-04-28 Ici Ltd Alkanolamine derivatives
SE8705150D0 (sv) * 1987-12-23 1987-12-23 Haessle Ab Novel antiarrhythmic agents

Also Published As

Publication number Publication date
KR920702676A (ko) 1992-10-06
LV10248A (lv) 1994-10-20
HU211024B (en) 1995-09-28
ZA904411B (en) 1991-02-27
ATE88698T1 (de) 1993-05-15
AU5851490A (en) 1991-01-08
DK0404748T3 (da) 1993-08-23
FI915937A7 (fi) 1991-12-17
CZ307190A3 (en) 1994-04-13
BG60164B2 (bg) 1993-11-30
IE902161A1 (en) 1991-01-02
CA2058941A1 (en) 1990-12-21
WO1990015794A1 (en) 1990-12-27
EP0404748B1 (en) 1993-04-28
NO914929D0 (no) 1991-12-13
IE902161L (en) 1990-12-20
US5055490A (en) 1991-10-08
HUT59084A (en) 1992-04-28
NZ234023A (en) 1992-03-26
PH27009A (en) 1993-02-01
HU905353D0 (en) 1992-03-30
PT94417A (pt) 1991-02-08
PL163988B1 (pl) 1994-06-30
YU120690A (sh) 1992-07-20
AU641665B2 (en) 1993-09-30
CN1048213A (zh) 1991-01-02
IL94677A0 (en) 1991-04-15
FI915937A0 (fi) 1991-12-17
NO914929L (no) 1991-12-13
PL285701A1 (en) 1991-01-28
ES2054325T3 (es) 1994-08-01
MX174254B (es) 1994-05-02
LTIP1727A (en) 1995-07-25
RU2032663C1 (ru) 1995-04-10
JPH04506076A (ja) 1992-10-22
CZ278988B6 (en) 1994-11-16
DE69001461D1 (en) 1993-06-03
SE8902237D0 (sv) 1989-06-20
HRP920625A2 (en) 1994-08-31
EP0404748A1 (en) 1990-12-27
DE69001461T2 (de) 1993-08-26

Similar Documents

Publication Publication Date Title
ES2070627T3 (es) Proceso para preparar (-)-((4-(1,4,5,6-tetrahidro-4-metil-6-oxo-3-piridacinil)fenil)-hidrazono)propanodinitrilo.
PT82610B (pt) Processo para a preparacao de tiazolidino-dionas hipoglicemicas
LU88842I2 (fr) Nebivolol optionnellement sous forme d'un sel ou d'un hydrate pharmaceutiquement acceptable en particulier hydroclorure de Nebivolol
CA2098302A1 (en) Medicaments
CA2059263A1 (en) Composition comprising the (-) enantiomer of cis-4-amino-1-(2-hydromethyl-1,3-oxathiolan-5-yl)-(1h)-pyrimidine-2-one or an enriched composition thereof, and its uses as a pharmaceutical agent
CA2122911A1 (en) 1,3-substituted cycloalkenes and cycloalkanes as central nervous system agents
WO1996015784A3 (de) 2,2-dichloralkancarbonsäuren, verfahren zu ihrer herstellung diese enthaltende arzneimittel, und ihre verwendung zur behandlung der insulinresistenz
RU93004860A (ru) Гетероциклические соединения, способ их получения, использование и фармацевтическая композиция
CA2190303A1 (en) Pharmaceutical composition, method and device for preventing or treating dry eye or disease caused therefrom
HU905353D0 (en) Process for the production of new stereoizomers
CA2027814A1 (en) Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds
HUT46508A (en) Insecticidal compositions comprising 6-member heterocyclic derivatives of n'-substituted-n,n'-diacylhydrazine and process for producing the active ingredients
CA2030346A1 (en) Treatment of cardiac dysfunction with 15-keto-prostaglandin compounds
ATE81007T1 (de) Wirkstoff mit die nierenfunktion verbesserndem und diuretischem effekt und verwendung eines darin enthaltenen benzothiazepin-derivates.
JO1646B1 (en) Innovative spaces (similarities)
ATE237619T1 (de) Sesquiterpen-derivate mit antiviraler aktivität
DE551180T1 (de) Verwendung von Bucillamin zur Herstellung eines Arzneimittels zur Behandlung von Cystinuria.
LTIP1724A (en) Polystyrenesulfonate, process for the preparation and use thereof
EP0209089A3 (en) Use of quinazolines in the preparation of a medicament for treating and preventing ischemic cardiac disease or arrhythmia
ZA908267B (en) 5-(2-((2-amino-2-oxoethyl)(methyl)amino)ethyl)-2,3-dihydro-3-hydroxy-2-(4-methoxyphenyl)-1,5(5h)-benzothiazepin-4-one derivatives,their preparation and their application in therapy
FR2648814B1 (fr) L'alpha (tert-butyl-aminomethyl-3,4-dichlorobenzyl)thioacetamide, son procede de preparation et son application en therapeutique
ES2078305T3 (es) 2-alquil-3-benzoilbenzofuranos utiles para el tratamiento de la arritmia cardiaca.
CA2154485A1 (en) Pharmaceutical composition containing 5-morpholinomethyl-3-(4-chlorobenzylideneamine)-2-oxazolidinone and its use for the treatment of cns disorders
DE3887174D1 (de) Verfahren zur Herstellung von 2,3-Dihydro-1H-imidazolylalkoxyinden-Derivaten und ihren pharmazeutisch annehmbaren Salzen, und Zwischenprodukte hierfür.
ATE109003T1 (de) Therapeutisches mittel gegen pollakiurie, harndrang oder harninkontinenz, das alpha-phenyl- alpha-pyridylalkan-carbonsäurederivate enthält.